Search

Predictive analytics in EHRs aren't yet effective enough for clinical decision support at the point of care.

While traditionally deeply skeptical of artificial intelligence in clinical settings, in today's fast-changing care delivery landscape many physicians are thinking more proactively about how AI can improve quality and patient experience.

The clinical manifestations of COVID-19 are varied, and patients are known to have rapidly changing signs and symptoms that must be tracked with laboratory testing.

Despite his high profile and the deep pockets of its investors, the Amazon, Berkshire Hathaway and JP Morgan Chase joint venture has so far shown limited progress on its aspirational tech-driven healthcare goals.

Despite one senator's hope to move deliberately with rulemakings and not repeat some errors of meaningful use, National Coordinator Donald Rucker said delays only lengthen the time that consumers are "not in control of their care."

More than a year after it was first announced, the joint venture between Amazon, Berkshire Hathaway and JPMorgan Chase finally has a new moniker.

HHS Secretary Alex Azar joins the roster, which also features Aneesh Chopra, Karen DeSalvo, Michael Levitt, Mick Ebeling, Seema Verma and Susan DeVore.

With EHR frustrations at a boiling point and physician burnout at epidemic levels, it's time to rethink the way IT is designed, developed and deployed to better enable a human touch, says one clinician.

The healthcare venture formed by Amazon, Berkshire Hathaway and JPMorgan Chase has hired insurance executive Dana Gelb Safran as head of measurement, a data-driven technology position, according to CNBC.